# Starco Brands, Inc.: financial statements, quarterly

STCB · OTC · CIK 1539850 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stcb.md) · [Financials](/companies/stcb/financials.md) · [Filings](/companies/stcb/filings.md) · [Insiders](/companies/stcb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stcb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.7](/filings/0001493152-23-040914.md) | [18.9 d](/filings/0001493152-24-013032.md) | [15.5](/filings/0001493152-24-019905.md) | [15.6](/filings/0001493152-24-032129.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | [9.4](/filings/0001493152-23-040914.md) | [12.7 d](/filings/0001493152-24-013032.md) | [8.5](/filings/0001493152-24-019905.md) | [9.9](/filings/0001493152-24-032129.md) | not reported | not reported | [6.1](/filings/0001493152-26-024612.md) | [6.6](/filings/0001493152-26-037882.md) | not reported | not reported | [5.1](/filings/0001493152-26-024612.md) | [4.6](/filings/0001493152-26-037882.md) |
| Gross profit | $m | [7.7](/filings/0001493152-24-045945.md) | [5.7 d](/filings/0001641172-25-005354.md) | [7.0](/filings/0001641172-25-011687.md) | [5.7](/filings/0001641172-25-023891.md) | [6.4](/filings/0001493152-25-023339.md) | [1.8 d](/filings/0001493152-26-016613.md) | [4.7](/filings/0001493152-26-024612.md) | [4.4](/filings/0001493152-26-037882.md) | [4.6](/filings/0001493152-25-023339.md) | [1.9 d](/filings/0001493152-26-016613.md) | [4.1](/filings/0001493152-26-024612.md) | [3.5](/filings/0001493152-26-037882.md) |
| Selling, general and administrative | $m | [5.0](/filings/0001493152-24-045945.md) | [6.9 d](/filings/0001641172-25-005354.md) | [5.3](/filings/0001641172-25-011687.md) | [4.5](/filings/0001641172-25-023891.md) | [4.2](/filings/0001493152-25-023339.md) | [4.8 d](/filings/0001493152-26-016613.md) | [3.4](/filings/0001493152-26-024612.md) | [3.2](/filings/0001493152-26-037882.md) | [3.1](/filings/0001493152-25-023339.md) | [3.5 d](/filings/0001493152-26-016613.md) | [2.4](/filings/0001493152-26-024612.md) | [2.2](/filings/0001493152-26-037882.md) |
| Operating income | $m | [2.7](/filings/0001493152-24-045945.md) | [(40.6) d](/filings/0001641172-25-005354.md) | [(4.0)](/filings/0001641172-25-011687.md) | [(11.1)](/filings/0001641172-25-023891.md) | [(5.6)](/filings/0001493152-25-023339.md) | [6.2 d](/filings/0001493152-26-016613.md) | [2.5](/filings/0001493152-26-024612.md) | [(1.4)](/filings/0001493152-26-037882.md) | [(1.1)](/filings/0001493152-25-023339.md) | [(18.9) d](/filings/0001493152-26-016613.md) | [(0.6)](/filings/0001493152-26-024612.md) | [(1.3)](/filings/0001493152-26-037882.md) |
| Interest expense | $m | [0.3](/filings/0001493152-23-040914.md) | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-024612.md) | [0.0](/filings/0001493152-26-037882.md) | not reported | not reported | [0.1](/filings/0001493152-26-024612.md) | [0.1](/filings/0001493152-26-037882.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [2.3](/filings/0001493152-24-045945.md) | [(40.8) d](/filings/0001641172-25-005354.md) | [(4.5)](/filings/0001641172-25-011687.md) | [(11.6)](/filings/0001493152-24-032129.md) | [(6.3)](/filings/0001493152-24-045945.md) | [4.7 d](/filings/0001493152-26-016613.md) | [1.9](/filings/0001493152-26-024612.md) | [(1.9)](/filings/0001493152-26-037882.md) | [(1.4)](/filings/0001493152-25-023339.md) | [(19.7) d](/filings/0001493152-26-016613.md) | [(0.8)](/filings/0001493152-26-024612.md) | [(1.4)](/filings/0001493152-26-037882.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-045945.md) | not reported | [(0.01)](/filings/0001641172-25-011687.md) | [(0.02)](/filings/0001641172-25-023891.md) | [(0.01)](/filings/0001493152-25-023339.md) | not reported | [0.00](/filings/0001493152-26-024612.md) | [0.00](/filings/0001493152-26-037882.md) | [0.00](/filings/0001493152-25-023339.md) | not reported | [0.00](/filings/0001493152-26-024612.md) | [0.00](/filings/0001493152-26-037882.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-045945.md) | not reported | [(0.01)](/filings/0001641172-25-011687.md) | [(0.02)](/filings/0001641172-25-023891.md) | [(0.01)](/filings/0001493152-25-023339.md) | not reported | [0.00](/filings/0001493152-26-024612.md) | [0.00](/filings/0001493152-26-037882.md) | [0.00](/filings/0001493152-25-023339.md) | not reported | [0.00](/filings/0001493152-26-024612.md) | [0.00](/filings/0001493152-26-037882.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-07-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.8](/filings/0001641172-25-005354.md) | [1.8](/filings/0001493152-24-019905.md) | not reported | [2.0](/filings/0001493152-24-032129.md) | [1.6](/filings/0001493152-24-045945.md) | [1.2](/filings/0001493152-26-016613.md) | [1.6](/filings/0001641172-25-011687.md) | [0.9](/filings/0001641172-25-023891.md) | [1.5](/filings/0001493152-25-023339.md) | [1.8](/filings/0001493152-26-037882.md) | [1.0](/filings/0001493152-26-024612.md) | [0.9](/filings/0001493152-26-037882.md) |
| Current assets | $m | [25.2](/filings/0001641172-25-005354.md) | [23.3](/filings/0001493152-24-019905.md) | not reported | [27.4](/filings/0001493152-24-032129.md) | [29.0](/filings/0001493152-24-045945.md) | [17.8](/filings/0001493152-26-016613.md) | [17.0](/filings/0001641172-25-011687.md) | [17.0](/filings/0001641172-25-023891.md) | [17.6](/filings/0001493152-25-023339.md) | [11.9](/filings/0001493152-26-037882.md) | [12.3](/filings/0001493152-26-024612.md) | [10.9](/filings/0001493152-26-037882.md) |
| Total assets | $m | [83.3](/filings/0001641172-25-005354.md) | [80.7](/filings/0001493152-24-019905.md) | not reported | [84.7](/filings/0001493152-24-032129.md) | [85.8](/filings/0001493152-24-045945.md) | [59.7](/filings/0001493152-26-016613.md) | [58.3](/filings/0001641172-25-011687.md) | [57.5](/filings/0001641172-25-023891.md) | [57.4](/filings/0001493152-25-023339.md) | [35.9](/filings/0001493152-26-037882.md) | [35.9](/filings/0001493152-26-024612.md) | [34.1](/filings/0001493152-26-037882.md) |
| Current liabilities | $m | [57.7](/filings/0001641172-25-005354.md) | [40.7](/filings/0001493152-24-019905.md) | not reported | [50.2](/filings/0001493152-24-032129.md) | [57.8](/filings/0001493152-24-045945.md) | [32.0](/filings/0001493152-26-016613.md) | [28.1](/filings/0001641172-25-011687.md) | [23.2](/filings/0001641172-25-023891.md) | [23.7](/filings/0001493152-25-023339.md) | [13.3](/filings/0001493152-26-037882.md) | [13.9](/filings/0001493152-26-024612.md) | [13.4](/filings/0001493152-26-037882.md) |
| Total liabilities | $m | [57.7](/filings/0001641172-25-005354.md) | [40.7](/filings/0001493152-24-019905.md) | not reported | [56.8](/filings/0001493152-24-032129.md) | [63.7](/filings/0001493152-24-045945.md) | [32.5](/filings/0001493152-26-016613.md) | [28.6](/filings/0001641172-25-011687.md) | [23.7](/filings/0001641172-25-023891.md) | [24.2](/filings/0001493152-25-023339.md) | [21.7](/filings/0001493152-26-037882.md) | [22.2](/filings/0001493152-26-024612.md) | [21.8](/filings/0001493152-26-037882.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [8.4](/filings/0001493152-24-013032.md) | [7.6](/filings/0001493152-24-019905.md) | [8.6](/filings/0001493152-24-032129.md) | not reported | [8.1](/filings/0001493152-24-045945.md) | [6.2](/filings/0001641172-25-005354.md) | [5.9](/filings/0001641172-25-011687.md) | [7.0](/filings/0001641172-25-023891.md) | [7.9](/filings/0001493152-25-023339.md) | not reported | not reported | not reported |
| Short-term borrowings | $m | [4.6](/filings/0001641172-25-005354.md) | [4.6](/filings/0001493152-24-019905.md) | not reported | [2.5](/filings/0001493152-24-032129.md) | [2.6](/filings/0001493152-24-045945.md) | [2.5](/filings/0001493152-25-023339.md) | [2.5](/filings/0001641172-25-011687.md) | [2.9](/filings/0001641172-25-023891.md) | [3.7](/filings/0001493152-25-023339.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [17.2](/filings/0001641172-25-005354.md) | [31.3](/filings/0001493152-24-019905.md) | [27.9](/filings/0001493152-25-023339.md) | [19.2](/filings/0001493152-24-032129.md) | [13.3](/filings/0001493152-24-045945.md) | [18.4](/filings/0001493152-26-016613.md) | [20.7](/filings/0001641172-25-011687.md) | [24.9](/filings/0001641172-25-023891.md) | [24.3](/filings/0001493152-25-023339.md) | [5.1](/filings/0001493152-26-037882.md) | [4.6](/filings/0001493152-26-024612.md) | [3.3](/filings/0001493152-26-037882.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(336) d](/filings/0001493152-24-045945.md) | [973 d](/filings/0001641172-25-005354.md) | [822](/filings/0001641172-25-011687.md) | [(698) d](/filings/0001641172-25-023891.md) | [393 d](/filings/0001493152-25-023339.md) | [1,698 d](/filings/0001493152-26-016613.md) | [839](/filings/0001493152-26-024612.md) | [(1,699) d](/filings/0001493152-26-037882.md) | [(317) d](/filings/0001493152-25-023339.md) | [276 d](/filings/0001493152-26-016613.md) | [(707)](/filings/0001493152-26-024612.md) | [(60.7) d](/filings/0001493152-26-037882.md) |
| Capital expenditure | $k | not reported | [17.8 d](/filings/0001641172-25-005354.md) | [26.9](/filings/0001641172-25-011687.md) | [5.3 d](/filings/0001641172-25-023891.md) | [187 d](/filings/0001493152-25-023339.md) | [90.9 d](/filings/0001493152-26-016613.md) | [111](/filings/0001493152-26-024612.md) | [1.6 d](/filings/0001493152-26-037882.md) | [(0.0) d](/filings/0001493152-25-023339.md) | [0.0 d](/filings/0001493152-26-016613.md) | not reported | not reported |
| Share repurchases | $k | [32.9 d](/filings/0001493152-24-045945.md) | [32.9 d](/filings/0001641172-25-005354.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [172](/filings/0001493152-23-040914.md) | [378](/filings/0001493152-23-018647.md) | [470](/filings/0001493152-24-032129.md) | [873](/filings/0001493152-24-045945.md) | [565](/filings/0001641172-25-011687.md) | [640](/filings/0001641172-25-023891.md) | [647](/filings/0001493152-25-023339.md) | [827](/filings/0001493152-26-024612.md) | [717](/filings/0001493152-26-037882.md) | [784](/filings/0001493152-25-023339.md) | [784](/filings/0001493152-26-024612.md) | [784](/filings/0001493152-26-037882.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 784,192,033 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-037882.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.